Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-07-28 Sale |
2021-07-30 09:15 am |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
2,130 | $19.24 | $40,973 | 99,931 (Indirect Direct) |
View |
2021-07-26 Sale |
2021-07-27 4:37 pm |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
7,250 | $19.69 | $142,776 | 86,685 (Direct) |
View |
2021-06-15 Sale |
2021-06-17 5:01 pm |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
5,000 | $19.42 | $97,122 | 15,200 (Direct) |
View |
2021-06-14 Sale |
2021-06-15 4:42 pm |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
2,075 | $19.34 | $40,132 | 12,925 (Direct) |
View |
2021-03-15 Sale |
2021-03-16 4:20 pm |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
18,000 | $17.72 | $319,010 | 148,935 (Direct) |
View |
2021-03-08 Sale |
2021-03-09 5:15 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
175,000 | $18 | $3,150,053 | 1,221,062 (Direct) |
View |
2021-03-05 Sale |
2021-03-08 5:47 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
5,600 | $17.85 | $99,966 | 86,926 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 6:43 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
19,530 | $18.58 | $362,850 | 92,526 (Direct) |
View |
2021-03-02 Sale |
2021-03-03 6:42 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,888 | $18.45 | $71,729 | 78,202 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 6:41 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
22,685 | $18.38 | $416,905 | 1,396,062 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 6:40 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
9,371 | $18.35 | $171,971 | 102,061 (Indirect Direct) |
View |
2021-03-02 Sale |
2021-03-03 6:40 pm |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
3,865 | $18.04 | $69,717 | 96,935 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 6:39 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
20,465 | $18.28 | $374,017 | 171,708 (Direct) |
View |
2021-02-24 Sale |
2021-02-26 5:17 pm |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
22,986 | $20.01 | $460,033 | 199,501 (Direct) |
View |
2021-02-16 Sale |
2021-02-18 8:43 pm |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
5,818 | $18.54 | $107,856 | 49,505 (Direct) |
View |
2021-02-16 Sale |
2021-02-18 8:43 pm |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
5,754 | $18.54 | $106,663 | 54,887 (Direct) |
View |
2020-12-11 Sale |
2020-12-15 4:24 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
125,252 | $13.04 | $1,633,510 | 1,458,593 (Direct) |
View |
2020-08-20 Sale |
2020-08-21 6:08 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,710 | $11.08 | $41,109 | 56,290 (Direct) |
View |
2020-08-14 Sale |
2020-08-17 4:42 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
3,684 | $11.81 | $43,526 | 79,356 (Direct) |
View |
2020-08-12 Sale |
2020-08-14 4:39 pm |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
7,200 | $11.81 | $85,018 | 75,487 (Direct) |
View |
2020-07-27 Sale |
2020-07-29 8:17 pm |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
7,313 | $10.62 | $77,631 | 82,687 (Direct) |
View |
2020-05-29 Sale |
2020-06-02 4:13 pm |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
9,677 | $11.5 | $111,286 | 35,323 (Direct) |
View |
2020-05-28 Sale |
2020-05-29 4:10 pm |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
10,129 | $11.04 | $111,806 | 40,641 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-06-15 Exercise |
2021-06-17 5:01 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
4,015 | $10.57 | 15,200 (Direct) |
View |
2021-06-15 Exercise |
2021-06-17 5:01 pm |
N/A 2030-06-10 |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
4,015 | $0 | 15,200 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:37 pm |
N/A 2031-06-09 |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $0 | 64,505 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:36 pm |
N/A 2031-06-09 |
Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director |
15,000 | $0 | 20,000 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:36 pm |
N/A 2031-06-09 |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
15,000 | $0 | 20,200 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:35 pm |
N/A 2031-06-09 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $0 | 69,887 (Direct) |
View |
2021-06-10 Option Award |
2021-06-14 4:34 pm |
N/A 2031-06-09 |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
15,000 | $0 | 25,000 (Direct) |
View |
2021-03-15 Exercise |
2021-03-16 4:20 pm |
N/A 2030-02-25 |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
15,000 | $0 | 148,935 (Direct) |
View |
2021-03-15 Exercise |
2021-03-16 4:20 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
15,000 | $11.32 | 148,935 (Direct) |
View |
2021-02-24 Option Award |
2021-02-26 5:19 pm |
N/A 2031-02-23 |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
110,200 | $0 | 189,556 (Direct) |
View |
2021-02-24 Option Award |
2021-02-26 5:19 pm |
N/A 2031-02-23 |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
87,000 | $0 | 143,290 (Direct) |
View |
2021-02-24 Option Award |
2021-02-26 5:18 pm |
N/A 2031-02-23 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
390,000 | $0 | 1,693,747 (Direct) |
View |
2021-02-24 Option Award |
2021-02-26 5:17 pm |
N/A 2031-02-23 |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
110,200 | $0 | 188,932 (Direct) |
View |
2021-02-24 Exercise |
2021-02-26 5:17 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
22,499 | $12.27 | 199,501 (Direct) |
View |
2021-02-24 Option Award |
2021-02-26 5:17 pm |
N/A 2031-02-23 |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
87,000 | $0 | 199,501 (Direct) |
View |
2021-02-24 Exercise |
2021-02-26 5:17 pm |
N/A 2029-07-24 |
Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer |
22,499 | $0 | 199,501 (Direct) |
View |
2021-02-24 Option Award |
2021-02-26 5:15 pm |
N/A 2031-02-23 |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
110,200 | $0 | 269,673 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 8:43 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $7.11 | 49,505 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 8:43 pm |
N/A 2021-06-15 |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $0 | 49,505 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 8:43 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $7.11 | 54,887 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 8:43 pm |
N/A 2021-06-15 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $0 | 54,887 (Direct) |
View |
2020-12-11 Exercise |
2020-12-15 4:24 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
150,000 | $8.75 | 1,458,593 (Direct) |
View |
2020-12-11 Exercise |
2020-12-15 4:24 pm |
N/A 2020-12-15 |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
150,000 | $0 | 1,458,593 (Direct) |
View |
2020-07-27 Option Award |
2020-07-29 8:19 pm |
N/A 2030-07-26 |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
107,344 | $0 | 168,732 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 7:13 pm |
N/A 2030-06-10 |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $0 | 50,323 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 7:12 pm |
N/A 2030-06-10 |
Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director |
15,000 | $0 | 15,000 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 7:11 pm |
N/A 2030-06-10 |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
15,000 | $0 | 15,200 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 7:11 pm |
N/A 2030-06-10 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $0 | 55,641 (Direct) |
View |
2020-06-11 Option Award |
2020-06-15 7:10 pm |
N/A 2030-06-10 |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
15,000 | $0 | 20,000 (Direct) |
View |
2020-05-29 Exercise |
2020-06-02 4:13 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $7.38 | 35,323 (Direct) |
View |
2020-05-29 Exercise |
2020-06-02 4:13 pm |
N/A 2020-06-02 |
Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director |
15,000 | $0 | 35,323 (Direct) |
View |
2020-05-28 Exercise |
2020-05-29 4:10 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $7.38 | 40,641 (Direct) |
View |
2020-05-28 Exercise |
2020-05-29 4:10 pm |
N/A 2020-06-02 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
15,000 | $0 | 40,641 (Direct) |
View |